Trials / Conditions / Blood and Marrow Transplant (BMT)

Blood and Marrow Transplant (BMT)

12 registered clinical trials studyying Blood and Marrow Transplant (BMT) — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG NCT00899847	Stanford University	Phase 2
Unknown	Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transpl NCT00185757	Robert Negrin	Phase 1
Completed	90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistan NCT00186589	Stanford University	Phase 1
Completed	Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders NCT00186576	Stanford University	N/A
Completed	High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma NCT00186394	Stanford University	Phase 2
Completed	Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease NCT00186667	Stanford University	Phase 2
Completed	Autologous Stem Cell Rescue for Primary Amyloidosis NCT00186407	Stanford University	Phase 2
Completed	Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remissio NCT00186381	Stanford University	Phase 2
Recruiting	Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation NCT01629017	Stanford University	—
Completed	Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies NCT00186342	Stanford University	N/A
Completed	Allo BMT in Advanced Leukemia or High Grade Lymphoma NCT00186290	Stanford University	N/A
Completed	Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors NCT00186225	Stanford University	N/A